01—Abstract
Summary
Summary of the 8-K filed March 30, 2026. Cited figures are marked; the original filing is the authoritative source.
Incyte Corporation disclosed in this Form 8-K, filed March 30, 2026, that Susanne Schaffert has resigned from the Company's Board of Directors, effective April 15, 2026.
Dr. Schaffert notified the Company of her resignation on March 26, 2026. She had served on the Board since 2022. The filing states that the resignation was not the result of any disagreement with the Company on matters relating to its operations, policies or practices.
The Board thanked Dr. Schaffert for her counsel and contributions during her service. The filing contains no financial results, guidance, or other operating information. Its substance is limited to this board departure, which is disclosed under Item 5.02 of Form 8-K.
02—Key points
Key Highlights
- Director resignation: Susanne Schaffert resigned from Incyte's Board of Directors, effective April 15, 2026.
- Notice date: Dr. Schaffert notified the Company of her resignation on March 26, 2026.
- Tenure: Dr. Schaffert had been a Board member since 2022.
- No disagreement: The filing states the resignation was not due to any disagreement with the Company on operations, policies or practices.
- Board statement: The Board thanked Dr. Schaffert for her counsel and contributions.
- Filing scope: The 8-K is limited to Item 5.02 and includes no financial or operating results.
03—Questions
Frequently Asked Questions
Who is leaving Incyte's Board of Directors?
Susanne Schaffert, who has served on the Board since 2022, is resigning. The filing refers to her as Dr. Schaffert.
When does the resignation take effect?
The resignation is effective as of April 15, 2026. Dr. Schaffert notified the Company of her decision on March 26, 2026.
Was the resignation related to a dispute with the company?
No. The filing states that the resignation was not the result of any disagreement with the Company on any matter relating to its operations, policies or practices.
Does this filing include financial results or guidance?
No. The filing addresses only the Item 5.02 board departure and contains no financial results, guidance, or other operating information.
04—Continue